Who owns Fypryst?
Fypryst is owned by Krka (Slovenia, LJSE: KRKG).[1]
This ownership is reported in official statements but has not yet been matched to a regulatory filing.
Evidence: Krka 2025 Annual Report, Krka, d. d., Novo mesto, 23 March 2026. Last checked .
Key facts
- Current owner
- Krka, tovarna zdravil, d. d., Novo mesto reported
- Owner HQ
- 🇸🇮 Slovenia, Novo mesto
- Origin
- 🇸🇮 Slovenia
- Category
- Pet & animal care › Pet supplies & services › Veterinary services
- Parent ticker
- LJSE: KRKG WSE: KRK
- Last verified
- · 1 sources
About Fypryst
Fypryst is Krka's fipronil-based spot-on treatment for cats and dogs and its second-largest animal health brand. Most of its sales are of Fypryst Combo, which adds S-methoprene against fleas and ticks. The strongest sales in 2025 came from the United Kingdom, the Russian Federation and France, Czech pharmacists named it the best antiparasitic for veterinary use, and the same fipronil is sold as Amflee, Fyperix and Fleaaway elsewhere.
Ownership timeline of Fypryst
Where Fypryst sits in Krka
Controlling ownership as of . Brands grouped under the entity that owns them; large groups are collapsed.
Open the full Krka ownership tree →
See the full Krka brand portfolio (18) →
Other brands owned by Krka
Krka controls 18 brands on Brandtree, 4 of them in pet & animal care.
Also in pet & animal care
Other brands in veterinary services, and who owns them
The 46 brands in veterinary services on Brandtree belong to 8 owners. The largest is Zoetis, with 17; Krka has 4.
| Brand | Owner | Owner based in |
|---|---|---|
| Apoquel | Zoetis | 🇺🇸 United States |
| Advantage | Elanco | 🇺🇸 United States |
| Caniviton | Vetoquinol | 🇫🇷 France |
| Banfield Pet Hospital | Mars | 🇺🇸 United States |
| Chewy Vet Care | Chewy | 🇺🇸 United States |
| Vets for Pets | Pets at Home | 🇬🇧 United Kingdom |
| Rejensa | Phibro | 🇺🇸 United States |
| Cerenia | Zoetis | 🇺🇸 United States |
About the owner: Krka
Krka is a publicly listed company headquartered in Novo mesto, Slovenia, founded in 1954. Brandtree records 18 brands under its control, and it is listed as LJSE: KRKG and WSE: KRK.
Krka is a Slovenian generic pharmaceutical maker established in Novo mesto in 1954, listed in Ljubljana since 1997 and dual-listed in Warsaw since 2012. Group revenue was €2,041.0 million in 2025 and net profit €403.7 million. Prescription medicines are the bulk of it, but Krka also sells non-prescription products and animal health products, and its Slovenian subsidiary Terme Krka runs four health resorts. At home it is the largest supplier of medicines by value and says one in every five medicines sold in Slovenia is its own.
🇸🇮 Fypryst and other Slovenian brands
Brandtree records a controlling owner for 31 brands that began in Slovenia. 10 of them (32%) are now controlled by a company headquartered in another country; Fypryst is not one of them.
Frequently asked questions
Who is the parent company of Fypryst?
The parent company of Fypryst is Krka, a publicly listed company headquartered in Slovenia.
Is Fypryst Slovenian?
Yes. Fypryst originated in Slovenia and its owner, Krka, is also headquartered in Slovenia.
Is Fypryst still owned by Krka?
Yes. As of 16 September 2026, Fypryst is still owned by Krka. The ownership record was last checked against primary sources on that date.
Sources (1) & corrections
Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.
- [1] Krka 2025 Annual Report — Krka, d. d., Novo mesto, Annual report, published 23 March 2026; retrieved 16 September 2026.
Report a correction Opens a pre-filled GitHub issue. See our corrections policy.